The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

June 14, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions
Bronchopulmonary Dysplasia
Interventions
DIAGNOSTIC_TEST

Breath test

Early detection of volatile organic compounds (VOCs) in breath from preterm infants, collected at several timepoints within the first 4 weeks of life to predict BPD before diagnosis is made at 36 weeks PMA.

OTHER

Throat swabs

A throat swab will be taken on several timepoints within the first 4 weeks of life to detect airway mucin expression. A second throat swab will be taken as proxy for the airway microbiome.

OTHER

Placental samples

After birth, placental biopsies will be collected for headspace VOCs analysis. A placental swab and a biopsy will be taken for microbiome analysis.

OTHER

Vaginal swab

A vaginal swab will be taken before birth for microbiome analysis.

OTHER

Endotracheal aspirates

Collection of aspirates, as part of routine care, to detect mucin expression and the lung microbiome.

Trial Locations (1)

2650

RECRUITING

University Hospital Antwerp, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER